Skip to menu Skip to content Skip to footer

2006

Book Chapter

Tumors, malignant: bronchogenic carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, malignant: bronchogenic carcinoma. Encyclopedia of respiratory medicine. (pp. 325-332) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00408-7

Tumors, malignant: bronchogenic carcinoma

2006

Conference Publication

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

2006

Journal Article

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27 (3), 525-532. doi: 10.1093/carcin/bgi227

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

2006

Journal Article

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

Coory, M., Fong, K., Bowman, R. and Hall, L. (2006). Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36 (6), 389-392. doi: 10.1111/j.1445-5994.2006.01074.x

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

2006

Book Chapter

Tumors, malignant: metastases from lung cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, malignant: metastases from lung cancer. Encyclopedia of respiratory medicine. (pp. 350-356) London, United Kingdom: Elsevier . doi: 10.1016/B0-12-370879-6/00412-9

Tumors, malignant: metastases from lung cancer

2006

Journal Article

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas

Heller, G., Fong, K. M., Girard, L., Seidl, S., End-Pfutzenreuter, A., Lang, G., Gazdar, A. F., Minna, J. D., Zielinski, C. C. and Zochbauer-Muller, S. (2006). Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene, 25 (6), 959-968. doi: 10.1038/sj.onc.1209115

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas

2006

Other Outputs

Bronchogenic Carcinoma

Bowman, R. V., Zimmerman, P. V. and Fong, K. M. (2006). Bronchogenic Carcinoma.

Bronchogenic Carcinoma

2006

Book Chapter

Tumors, malignant: overview

Fong, K. M., Zimmerman, P. V. and Bowman, R. V. (2006). Tumors, malignant: overview. Encyclopedia of respiratory medicine. (pp. 320-325) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00406-3

Tumors, malignant: overview

2006

Book Chapter

Hematological Malignancies

Wood, P. and Fong, K. M. (2006). Hematological Malignancies. Encyclopedia of Respiratory Medicine. (pp. 339-344) edited by Geoffrey J. Laurent and Steven D. Shapiro. New York: Academic Press (Elsevier). doi: 10.1016/B0-12-370879-6/00410-5

Hematological Malignancies

2006

Other Outputs

Tumors, Malignant: Carcinoma, Lymph Node Involvement

Fong, K. M., Windsor, M., Bowman, R. V. and Duhig, E. (2006). Tumors, Malignant: Carcinoma, Lymph Node Involvement.

Tumors, Malignant: Carcinoma, Lymph Node Involvement

2006

Other Outputs

Tumors, Malignant: Metastases from Lung Cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, Malignant: Metastases from Lung Cancer.

Tumors, Malignant: Metastases from Lung Cancer

2006

Book Chapter

Tumors, malignant: carcinoma, lymph node involvement

Fong, K. M., Windsor, M., Bowman, R. V. and Duhig, E. (2006). Tumors, malignant: carcinoma, lymph node involvement. Encyclopedia of respiratory medicine. (pp. 366-373) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00407-5

Tumors, malignant: carcinoma, lymph node involvement

2006

Book Chapter

TUMORS, MALIGNANT | Metastases from Lung Cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). TUMORS, MALIGNANT | Metastases from Lung Cancer. Encyclopedia of Respiratory Medicine: Volume 1-4. (pp. V4-350-V4-356) Elsevier. doi: 10.1016/B0-12-370879-6/00412-9

TUMORS, MALIGNANT | Metastases from Lung Cancer

2006

Other Outputs

Tumors, Malignant: Bronchogenic Carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Bronchogenic Carcinoma.

Tumors, Malignant: Bronchogenic Carcinoma

2005

Journal Article

Cochrane systematic reviews of treatments for lung cancer

Fong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002

Cochrane systematic reviews of treatments for lung cancer

2005

Journal Article

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

Zochbauer-Muller, Sabine, Fong, Kwun M., Geradts, Joseph, Xu, Xie, Seidl, Sonja, End-Pfützenreuter, Adelheid, Lang, György, Heller, Gerwin, Zielinski, Christoph C., Gazdar, Adi F. and Minna, John D. (2005). Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene, 24 (41), 6249-6255. doi: 10.1038/sj.onc.1208775

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

2005

Journal Article

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

2005

Journal Article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

Tothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D.L. and Holloway, A.J. (2005). An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65 (10), 4031-4040. doi: 10.1158/0008-5472.CAN-04-3617

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

2005

Journal Article

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Shigematsu, Hisayuki, Lin, Li, Takahashi, Takao, Nomura, Masaharu, Suzuki, Makoto, Wistuba, Ignacio I., Fong, Kwun M., Lee, Huei, Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Feng, Ziding, Roth, Jack A., Herz, Joachim, Minna, John, D. and Gazdar, Adi, F. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute, 97 (5), 339-346. doi: 10.1093/jnci/dji055

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

2005

Journal Article

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Shigematsu, Hisayuki, Takahashi, Takao, Nomura, Masaharu, Majmudar,Kuntal, Suzuki, Makoto, Lee, Huei, Wistuba, Ignacio I., Fong, Kwun M., Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Minna, John D. and Gazdar, Adi F. (2005). Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Research, 65 (5), 1642-1646. doi: 10.1158/0008-5472.CAN-04-4235

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas